Effective and quick arterial blood gas test are necessary to evaluate respiratory function and pH balance. Arterial blood gas analysis plays a critical role in diagnosing, treating and reducing the incidence and mortality rate of various diseases including viral hemorrhagic fevers such as Ebola. In keeping with the need for comprehensive evaluation, modern blood gas analyzers provide results for a wide combination of parameters. Global leader in vitro diagnostics Siemens Healthcare Diagnostics has always been in the forefront in providing point-of-care testing (POCT) products that ensure optimized clinical outcomes. The company’s blood gas family comprises versatile instruments that feature a comprehensive testing menu and provide results in minutes. In a recent interview with News Medical, David Stein, PhD, CEO, Point of Care, Siemens talked about the company’s customer-centric blood gas solutions – how they developed over the years, and future plans and challenges.
The advanced blood gas systems from Siemens can deliver results for pH, blood gases, electrolytes, metabolites, CO-oximetry, and a variety of calculated parameters.
Starting from a blood gas analyzer for pH, pO2, and pCO2 in 1968, Siemens and its predecessor companies have shaped the status of how and where testing takes place today. From conventional centralized testing in the hospital laboratory, the company has pioneered POCT systems that provide results in multiple critical care locations. The latest systems provide lactate and bilirubin tests, accept pleural fluid and dialysate samples, integrate bar-code scanning, and support wireless connectivity.
Siemens blood gas systems are popular for the positive impact they have made on patient workflow and medical outcomes. The important factors that establish the company as a leader in the field are:
- Careful honing of design, technology, and product attributes of blood gas instruments to meet customer needs
- Instruments that allow hospital nurses and doctors to run tests where and when they are needed most, enhancing care in respiratory therapy, labor and delivery, the ICU, the OR, and the ED
- Focus on developing blood gas solutions that will lower cost of operation and improve clinical outcomes and value with expanded test menus, reduced sample-size requirements, reduced maintenance, and expanded connectivity to include wireless and open systems.
Novel Solutions to Address the Challenges of Varied Clinical Settings
Siemens also offers a selection of RAPIDlab 1200 blood gas analyzers that allow critical-care testing to be performed in several different locations throughout a hospital such as the RAPIDLab® 348EX System for low-volume settings, RAPIDPoint® 500 System for mid-volume settings, and the high-volume RAPIDLab® 1200 Series Blood Gas Systems. Some of the advanced features of this systems include –
- Comprehensive test menu that addresses a variety of critical care testing needs
- Intuitive operation and minimal maintenance
- Industry-proven accuracy and reliability through long-life Ready Sensor® electrode technology
- Biosafe automatic sampling system with clot detection and clearance
- Effortless onboard Automatic Quality Control (AQC) for enhanced quality assurance and regulatory compliance
What’s notable is that Siemens ensures harmonization across all these systems, so that the same clinical decisions are made for the patient, regardless of which system performed the blood gas test and where. This enables appropriate and consistent therapeutic actions.
On plans for the future, Dr Stein pointed out that Siemens will continue to develop customer-centric solutions that advance clinical value, utility, and convenience, and with pioneering additions to their POCT portfolio.